In vitro evaluation of combination drug purging for autologous bone marrow transplantation

R. J. Jones, C. B. Miller, B. A. Zehnbauer, S. D. Rowely, O. M. Colvin, L. L. Sensenbrenner

Research output: Contribution to journalArticle

Abstract

Using an in vitro model, we studied whether combining 4-hydroperoxycyclophosphamide (4HC) with other drugs could improve its effectiveness as an ex vivo purging agent for autologous bone marrow transplantation. 4HC was incubated simultaneously with vincristine and etopside, and sequentially with methylprednisolone, in various combinations. Compared to 4HC alone, all drug combinations increased the kill of leukemia cell lines K562 and CEM without increasing the kill of granulocyte- macrophage colony-forming units (CFU-GM). The combination of 4HC, vincristine and methylprednisolone was the most active, and this drug combination was also the only combination which showed improved selective cytotoxicity (compared to 4HC alone) toward REH cells. This combination inhibited at least 8 logs of clonogenic leukemia cells from all three lines at doses which spared 1% of CFU-GM. This was an increase of 1.7 to 6.6 logs of clonogenic leukemia cell kill over 4HC alone. This drug combination displayed similar differential activity between fresh clonogenic leukemia cells and CFU-GM cultured from the bone marrows of seven patients about to undergo autologous bone marrow transplantation for acute lymphocytic leukemia.

Original languageEnglish (US)
Pages (from-to)301-307
Number of pages7
JournalBone marrow transplantation
Volume5
Issue number5
StatePublished - Jan 1 1990

    Fingerprint

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Jones, R. J., Miller, C. B., Zehnbauer, B. A., Rowely, S. D., Colvin, O. M., & Sensenbrenner, L. L. (1990). In vitro evaluation of combination drug purging for autologous bone marrow transplantation. Bone marrow transplantation, 5(5), 301-307.